Magenta Therapeutics unveils plans to raise $100M in IPO weeks after a crossover round
Just weeks after bagging $52 million from venture capitalists in a crossover round, Cambridge, MA darling Magenta Therapeutics has declared intentions to list on the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.